INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance

30 أكتوبر 2024 06:30:35 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

17 أكتوبر 2024 07:00:33 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

23 سبتمبر 2024 07:00:34 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

28 أغسطس 2024 07:00:04 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

08 أغسطس 2024 07:00:26 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Appointment of Sanjeev Narula as Chief Financial Officer

07 أغسطس 2024 06:40:54 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 CAPLYTA Sales Guidance

07 أغسطس 2024 06:30:38 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast

24 يوليو 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

18 يونيو 2024 06:30:16 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

10 يونيو 2024 07:00:34 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

29 مايو 2024 07:00:54 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting

23 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

08 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports First Quarter 2024 Financial Results

07 مايو 2024 06:30:00 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

30 أبريل 2024 07:00:53 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

24 أبريل 2024 15:01:19 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Prices Public Offering of Common Stock

17 أبريل 2024 19:46:08 بحسب Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

16 أبريل 2024 15:06:34 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

16 أبريل 2024 08:45:25 بحسب NetDania Notify

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

16 أبريل 2024 06:00:53 بحسب Nasdaq GlobeNewswire